The researchers extracted adult human fat cells and injected them with compound 5-Azacytidine and platelet-derived growth factor-AB.
Here are four insights:
1. The researchers implanted the induced multipotent stem cells on damaged tissue in mice to see if they would grow and heal tissue.
2. The experiments have proved successful.
3. The researchers expect to conduct human trials by late 2017, and believe the iMS cells could help patients with spinal cord injuries.
4. Further studies are needed to determine whether iMS cells stay dormant or react when needed.
More articles on spine:
DISC Sports & Spine Center: 5 ways to avoid injuries when returning to exercise
Dr. Neal Kassell named to NCI’s Blue Ribbon Panel for cancer moonshot initiative: 4 notes
How cervical disc arthroplasty can impact patient depression — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
